Long‐acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population‐based cohort study
We did not find an association between use of a long-acting insulin analogue, compared with use of NPH insulin, and the risk of diabetic nephropathy among patients with T2D.
Authors
- Christopher Filliter
- Julia Brillinger (ORCID: https://orcid.org/0000-0001-8430-1967)
- Kristian B. Filion (ORCID: https://orcid.org/0000-0001-6055-0088)
- Robert Platt
- Oriana H. Y. Yu
- Shahrzad Salmasi
- Estefania Zapata‐Bravo
Institutions
- Jewish General Hospital (CA)
- McGill University (CA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1111/dom.70397
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McGill University
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé